Randomised, double-blind, multicentre, phase Ⅰ/Ⅱ dose escalation and expansion trial of GR1501 in patients with plaque psoriasis: study protocol

INTRODUCTION: Psoriasis is a life-long, immune-mediated disease that greatly reduces the quality of life of patients. Plaque psoriasis is the most common form of psoriasis. Treatment options for plaque psoriasis with good tolerance and sufficient response remain profoundly limited. Based on mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Wenliang, Nie, Xiaoyan, Wang, Jiaxue, Xia, Lin, Cai, Lin, Wang, Qian, Wang, Wei, Fu, Weixing, Wang, Qi, Shen, Tiantian, Fan, Huaying, Niu, Suping, Cui, Yimin, Zheng, Qingshan, Zhang, Jianzhong, Fang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689088/
https://www.ncbi.nlm.nih.gov/pubmed/33234634
http://dx.doi.org/10.1136/bmjopen-2020-039067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689088/
https://www.ncbi.nlm.nih.gov/pubmed/33234634
http://dx.doi.org/10.1136/bmjopen-2020-039067

Ejemplares similares